At Pratia, we specialize in approximately 85% of all therapeutic areas, offering comprehensive research services across a wide range of clinical trials.
Therapeutic Areas and Capabilities
:quality(70))
Oncology
Healthy volunteers, early phase and specialized fields like tabacco and medical devices
Biosampling
Robust trial conduct in vaccines, obesity post-marketing (phase IV) studies
Specialty care
Our expertise in Oncology
Oncology research is complex, involving intricate protocols, rapidly evolving treatments, and a critical need for innovative therapies to tackle diverse cancers. Challenges like patient recruitment, biomarker-driven designs, and strict regulatory demands require deep expertise and flexible strategies.
Pratia’s extensive experience enables us to overcome these hurdles and deliver high-quality, efficient trials that advance cutting-edge cancer treatments and improve patient outcomes globally.
7
owned exclusive oncology units
:quality(70))
One of the global leaders
in oncology clinical trial conduct
:quality(70))
600+
active clinical trials annually
over 30%
of our experience is in oncology
5
countries
400+
Combined years of PI’s experience
:quality(70))
15.2 mln
Patients in reach of our oncology sites
7
owned exclusive oncology units
One of the global leaders
in oncology clinical trial conduct
600+
active clinical trials annually
over 30%
of our experience is in oncology
5
countries
400+
Combined years of PI’s experience
15.2 mln
Patients in reach of our oncology sites
7
owned exclusive oncology units
One of the global leaders
in oncology clinical trial conduct
600+
active clinical trials annually
over 30%
of our experience is in oncology
5
countries
400+
Combined years of PI’s experience
15.2 mln
Patients in reach of our oncology sites
7
owned exclusive oncology units
One of the global leaders
in oncology clinical trial conduct
600+
active clinical trials annually
over 30%
of our experience is in oncology
5
countries
400+
Combined years of PI’s experience
15.2 mln
Patients in reach of our oncology sites
Scientific Leadership
With a team of dedicated Key Opinion Leaders (KOLs), Pratia remains at the forefront of research innovation. Some of our KOLs:
Our expertise in Vaccines
Pratia has extensive experience in vaccine research, with expertise in Phase I-IV trials for both adult and pediatric populations. We specialize in a wide range of vaccine technologies, including mRNA, viral vectors, recombinant proteins, and more. Our studies cover numerous indications such as COVID-19, Influenza, HIV, HPV, and others. Pratia is known for its ability to meet and exceed enrollment targets, consistently achieving 100%-150%, or even up to 300%, of recruitment goals. This ensures that vaccine development progresses efficiently, meeting timelines with precision and excellence.
:quality(70))
Our expertise in Specialty Care
Our specialty care experience and expertise extends across the following therapeutic areas:
Vascular Diseases
Cardiology
Nephrology
Dermatology
Rheumatology
Gastrology
Urology
Pulmonology
Hematology
Metabolic Diseases
Pediatrics
Surgery
Our biosampling capabilities
Biosampling at Pratia plays a vital role in advancing high-quality clinical research.
We offer comprehensive solutions for the collection, processing, and storage of biological samples - such as blood, tissue, and other fluids - while ensuring full regulatory compliance and sample integrity.
Biomarker analysis
Pharmacokinetics
Personalized medicine
Our expertise in Healthy Volunteers
With over 25 years of experience, our Phase I flagship site in Warsaw, Poland, has successfully conducted 480+ clinical research projects and completed 74 audits, including 5 FDA inspections with NAI results. We provide full-service solutions for early-phase studies, bioequivalence and biosimilarity, Proof-of-Concept and PK/PD studies, special populations, and tobacco risk evaluation and smoking cessation.
:quality(70))
Ready to start your clinical trial?
Discover how our flexible approach can support your unique study needs.